|
KDM4D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.265000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.164200E-01 |
| Normal-vs-Stage2 |
3.640600E-01 |
| Normal-vs-Stage3 |
9.276600E-01 |
| Normal-vs-Stage4 |
1.102230E-01 |
| Stage1-vs-Stage2 |
9.800200E-01 |
| Stage1-vs-Stage3 |
4.262800E-01 |
| Stage1-vs-Stage4 |
4.110600E-01 |
| Stage2-vs-Stage3 |
5.656600E-01 |
| Stage2-vs-Stage4 |
4.475600E-01 |
| Stage3-vs-Stage4 |
2.932600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.641000E-01 |
| Normal-vs-AfricanAmerican |
3.256600E-01 |
| Normal-vs-Asian |
1.100290E-02 |
| Caucasian-vs-AfricanAmerican |
7.726800E-01 |
| Caucasian-vs-Asian |
6.667900E-02 |
| AfricanAmerican-vs-Asian |
4.890300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.432600E-01 |
| Normal-vs-Female |
8.746200E-01 |
| Male-vs-Female |
1.369980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.596600E-01 |
| Normal-vs-Extreme_Weight |
9.042200E-02 |
| Normal-vs-Obese |
9.904400E-01 |
| Normal-vs-Extreme_Obese |
1.484350E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.252800E-01 |
| Normal_Weight-vs-Obese |
4.886000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.174200E-01 |
| Extreme_Weight-vs-Obese |
6.043600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.524400E-01 |
| Obese-vs-Extreme_Obese |
6.214400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.723000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.339600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.738180E-01 |
| Normal-vs-Age(81-100Yrs) |
4.944400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.860620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.150010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.812000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.371600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.166400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.792400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.207000E-01 |
| Normal-VS-Type2 PRCC |
2.442200E-02 |
| Normal-VS-KIRP CIMP |
1.645410E-01 |
| Normal-VS-Unclassified PRCC |
7.526400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.421590E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.220200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.009600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.602200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.437750E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.967750E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.434100E-02 |
| Normal-vs-N1 |
9.652400E-01 |
| Normal-vs-N2 |
1.353750E-01 |
| N0-vs-N1 |
2.583000E-01 |
| N0-vs-N2 |
5.054400E-01 |
| N1-vs-N2 |
4.274000E-01 |
|
|
